Modeling of the impact on health outcomes of the use of dabigatran in patients with atrial fibrillation
J Chevalier, M Giroud, G De Pouvourville - Cerebrovascular Diseases, 2013 - karger.com
… during treatment with aspirin compared to warfarin is 0.55 [8]. … In France, dabigatran has
obtained a flat daily price for both … : Cost-effectiveness of dabigatran etexilate for the prevention …
obtained a flat daily price for both … : Cost-effectiveness of dabigatran etexilate for the prevention …
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis—Task Force on Anticoagulants in Heart Disease …
Coordinating Committee, R De Caterina… - Journal of the American …, 2012 - jacc.org
… to both warfarin and aspirin for stroke prevention in a broad population with … the cost-effectiveness
at a societal level might be tolerable in comparison with other recently accepted novel …
at a societal level might be tolerable in comparison with other recently accepted novel …
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert consensus …
… of oral anticoagulation in patients with atrial fibrillation (AF) … NOACs (apixaban[15] and
rivaroxaban[16]) as with aspirin or … population treated with dabigatran or warfarin, demonstrated …
rivaroxaban[16]) as with aspirin or … population treated with dabigatran or warfarin, demonstrated …
Warfarin and atrial fibrillation: from ideal to real the warfarin affaire
M Molteni, C Cimminiello - Thrombosis Journal, 2014 - Springer
… This meta-analysis also compared VKAs with aspirin alone: … direct comparison of warfarin
to the new oral anticoagulants (… prediction of warfarin dose, its cost-effectiveness is still …
to the new oral anticoagulants (… prediction of warfarin dose, its cost-effectiveness is still …
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled …
D Vinereanu, SR Stevens, JH Alexander… - European heart …, 2015 - academic.oup.com
… factor for stroke and treated with oral anticoagulants, women … enzyme inhibitors, β-blockers,
aspirin, and statins, but women … largest published report comparing background factors and …
aspirin, and statins, but women … largest published report comparing background factors and …
Cost-effectiveness analysis of direct oral anticoagulants versus vitamin k antagonists for venous thromboembolism in China
KX Sun, B Cui, SS Cao, QX Huang, RY Xia… - Frontiers in …, 2021 - frontiersin.org
… (RIV), dabigatran (DAB), and low molecular weight heparin (… ), it is limited to patients with
non-valvular atrial fibrillation and … study is to compare the cost-effectiveness of four regimens at …
non-valvular atrial fibrillation and … study is to compare the cost-effectiveness of four regimens at …
Safety and efficacy of oral anticoagulants therapies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis
… of anticoagulant and P2Y12 inhibitors (with and without aspirin) in … comparing the efficacy
of apixaban versus warfarin in … A cost-effectiveness analysis based on real-world data from …
of apixaban versus warfarin in … A cost-effectiveness analysis based on real-world data from …
… costs and utilization of Dabigatran compared with Warfarin for secondary stroke prevention in patients with nonvalvular atrial fibrillation: a retrospective population …
… Most cost-effectiveness studies of NOACs focused on … aimed to compare the health care
costs and utilization between … warfarin and dabigatran, or other novel oral anticoagulants, and …
costs and utilization between … warfarin and dabigatran, or other novel oral anticoagulants, and …
Non–vitamin K antagonist oral anticoagulants in the treatment of atrial fibrillation
AC Fanaroff, EM Ohman - Annual review of medicine, 2019 - annualreviews.org
… comparing warfarin to placebo in patients with AF, the HR for … dose of dabigatran was not
approved for stroke prevention by … choose aspirin over oral anticoagulation in these patients in …
approved for stroke prevention by … choose aspirin over oral anticoagulation in these patients in …
PCV48 Systematic Review of Cost-Effectiveness Models for Pharmacologic Stroke Prevention in Atrial Fibrillation
… The aim of this study was to compare the cost-effectiveness of … Dabigatran is a novel oral
anticoagulant associated with … plus aspirin (group 1) compared with clopidogrel plus aspirin (…
anticoagulant associated with … plus aspirin (group 1) compared with clopidogrel plus aspirin (…